Evidence map›Paper›PMID 39030724›Full record

ArticleJournal of leukocyte biology2024

The enigmatic AHRR: beyond aryl hydrocarbon receptor repression.

Mark E Hahn, David H Sherr

Abstract readEditorialComment
In one paragraph

Article in Journal of leukocyte biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Mark E HahnBiology Department, MS-32, Woods Hole Oceanographic Institution, Woods Hole, MA 02543, USA.ORCID 0000-0003-4358-2082
David H SherrDepartment of Environmental Health, Housman R-408, Boston University School of Public Health, 72 E. Concord St, Boston, MA 02118, USA.

Funding

AHR-mediated immunosuppression in glioblastomaR01ES029136 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI Francisco J. Quintana, DAVID A REARDON · 2019 to 2026
$3.3M
Mechanisms Controlling Sensitivity and Resistance to Dioxin-like Compounds: Role of AIPR01ES033888 · NIEHS · WOODS HOLE OCEANOGRAPHIC INSTITUTION · PI Mark E Hahn · 2022 to 2026
$3.2M
Understanding the origins and mechanisms of aryl hydrocarbon receptor promiscuityR01ES035261 · NIEHS · WOODS HOLE OCEANOGRAPHIC INSTITUTION · PI Mark E Hahn · 2023 to 2026
$2.0M
An Environmental Chemical Receptor, the AhR, as a Mediator of Multiple Immune Checkpoints in Oral CancerR01ES033692 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SHERR, DAVID H · 2022 to 2024
$1.4M
Find The Cause Breast Cancer FoundationHahnemann FoundationNIEHS NIH HHS R01 ES029136NIEHS NIH HHS R01 ES033692NIEHS NIH HHS R01 ES033888NIEHS NIH HHS R01 ES035261
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AHR repressoraryl hydrocarbon receptoreosinophilsintestinemucosal immunology

Identifiers

PMID39030724
PMCPMC11531999

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.